SCHEMBL15469461

SCHEMBL15469461

Cc1ccc([C@@]2(N)CCOc3cccnc32)cc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 4/20 0.33
NPC1 O15118 3/20 0.33
P2RX7 Q99572 1/20 0.32
ICMT O60725 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
GRM4 Q14833 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
CYP3A4 P08684 1/20 0.31
PDE2A O00408 1/20 0.31
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15467738 0.90 TRPV3 (0.38) RAB9ANPC1MAPTTRPM8
SCHEMBL15467739 0.90 TRPV3 (0.38) RAB9ANPC1MAPTTRPM8
Hydrochloric Acid SCHEMBL15567400 0.89 TRPV3 (0.38) SMN1; SMN2RAB9ANPC1MAPT
Hydrochloric Acid SCHEMBL15567395 0.89 TRPV3 (0.38) SMN1; SMN2RAB9ANPC1MAPT
SCHEMBL16418774 0.88 NOS3 (0.33) MAP3K14ALDH1A1RAB9ATRPM8
SCHEMBL15469414 0.85 TRPM8 (0.33) MAP3K14RAB9AGRM4TRPM8
SCHEMBL15469386 0.85 TRPM8 (0.33) MAP3K14RAB9AGRM4TRPM8
SCHEMBL15467667 0.83 TRPM8 (0.35) P2RX7GRM4TRPM8
SCHEMBL15467665 0.83 TRPM8 (0.35) P2RX7GRM4TRPM8
SCHEMBL15469390 0.83 AKT1 (0.33) SMN1; SMN2ALDH1A1GAAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952009-B2 Chroman derivatives as TRPM8 inhibitors AMGEN INC. (US) 2015-02-10 US disclosed
US-20150031668-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC (US) 2015-01-29 US disclosed
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS AMGEN INC. (US) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031668-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS TRPM8, TRPM5, TRPM7 MAP3K14 1097/4885SMN1; SMN2 923/4885ALDH1A1 4469/4885
US-20140045855-A1 CHROMAN DERIVATIVES AS TRPM8 INHIBITORS TRPM8, TRPM5, TRPM7 MAP3K14 1097/4885SMN1; SMN2 923/4885ALDH1A1 4469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.